Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 9 of 9 for “"S1P pathway"”.

  1. Experimental study of fertility alterations, immune microenvironment changes, and S1P pathway targeting in a murine model of adenomyosis.

    … et la signalisation sphingosine-1-phosphate (S1P). Les résultats de ce travail suggèrent qu’une adénomyose diffuse est suffisante pour perturber la folliculogenèse, modifier les cycles oestraux et altérer précocement des marqueurs clés de la réceptivité endométriale, avant l’installation d’une …

    liege Repository record for Experimental study of fertility alterations, immune microenvironment changes, and S1P pathway targeting in a murine model of adenomyosis. (opens in a new tab) Download PDF for Experimental study of fertility alterations, immune microenvironment changes, and S1P pathway targeting in a murine model of adenomyosis. (opens in a new tab)

  2. SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS

    … HYPOXIA INDUCIBLE FACTOR (HIF)-1A, SPHK2, S1P, AND NG2 UP-REGULATION TOGETHER WITH ACCUMULATION OF WML. IN ADDITION, SPHK INHIBITOR SKI-II SHOWED PARTIAL REVERSAL OF SPHK2, S1P AND NG2 ELEVATION AND AMELIORATION OF WML. IN AN IN VITRO MODEL OF HYPOXIA, SKI-II REVERSED THE SUPPRESSION OF OPC …

    nus Repository record for SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS (opens in a new tab) Download file for SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS (opens in a new tab)

  3. Improving Potency and Oral Bioavailability of Spinster Homolog 2 (Spns2) Inhibitor: A Structure-Activity Relationship Study

    The sphingosine-1-phosphate (S1P) pathway is a therapeutic target for drug discovery due to its involvement in autoimmune diseases such as multiple sclerosis (MS) and ulcerative colitis (UC) as well as renal fibrosis (RF). S1P is synthesized from sphingosine that is phosphorylated by sphingosine …

    vt Repository record for Improving Potency and Oral Bioavailability of Spinster Homolog 2 (Spns2) Inhibitor: A Structure-Activity Relationship Study (opens in a new tab)

  4. Translation of Sphingosine-1-phosphate-dependent Regulation of Myogenic Tone in Human Resistance Arteries with Heart Failure

    … are poorly understood. Sphingosine-1-phosphate (S1P) is a key regulator of the myogenic response in rodents. In mice with heart failure, the myogenic response is increased due to tumour necrosis factor alpha (TNF-alpha) and cystic fibrosis transmembrane conductance regulator (CFTR)-dependent …

    toronto-retro Repository record for Translation of Sphingosine-1-phosphate-dependent Regulation of Myogenic Tone in Human Resistance Arteries with Heart Failure (opens in a new tab)

  5. The TNFα/S1P Signalling Axis Mediates Elevated Myogenic Tone in Diabetes Mellitus

    … bioactive sphingolipid sphingosine-1-phosphate (S1P) is a central regulator of the myogenic response, with the pressure-induced activation of the S1P-generating enzyme sphingosine kinase 1 (Sphk1) and activation of the S1P2 receptor (S1P2R) as key elements. This signalling pathway and hence, …

    toronto-retro Repository record for The TNFα/S1P Signalling Axis Mediates Elevated Myogenic Tone in Diabetes Mellitus (opens in a new tab)

  6. Developing Sphingosine-1-Phosphate (Spns2) Inhibitors for the Treatment of Multiple Sclerosis

    Sphingosine-1-phosphate (S1P) is a ubiquitous signaling molecule. S1P is formed from sphingosine via phosphorylation by one of its two kinases (SphK1 and SphK2). Once produced, it can be exported out of the cell by Spinster homologue 2 (Spns2) or major facilitator domain containing 2B (mfsd2b) …

    vt Repository record for Developing Sphingosine-1-Phosphate (Spns2) Inhibitors for the Treatment of Multiple Sclerosis (opens in a new tab)

  7. Cytotoxic Activity of Sphingosine-1-Phosphate against Human Triple-negative/ Basal-like Breast Cancer

    … sphingosine, and sphingosine-1-phosphate (S1P), are implicated in cancer. S1P exerts its functions via extracellular and intracellular targets. S1P synthesized inside the cell is exported outside and binds to G-protein coupled receptors, the sphingosine-1-phosphate receptors 1-5 (S1PR1-5). …

    sask Repository record for Cytotoxic Activity of Sphingosine-1-Phosphate against Human Triple-negative/ Basal-like Breast Cancer (opens in a new tab)

  8. Evaluating Fty720 As An Anticancer Agent In Models Of Ovarian Cancer

    Despite satisfactory initial responses to frontline therapies that combine tumor debulking with platinum and taxane-based chemotherapies, ovarian cancer remains the principle cause of gynecological malignancies. Drug resistance at relapse contributes to poor outcomes for women diagnosed with …

    uab Repository record for Evaluating Fty720 As An Anticancer Agent In Models Of Ovarian Cancer (opens in a new tab)

  9. ROLE OF SPHINGOSINE-1-PHOSPATE PATHWAY IN INTESTINAL EPITHELIAL CELLS AND ITS INVOLVEMENT IN INTESTINAL TUMORIGENESIS.

    Title: Role of Sphingosine-1-phosphate pathway in intestinal epithelial cells and its involvement in intestinal tumorigenesis. Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite, involved in several cellular processes. S1P is both an intracellular second messenger and the ligand …

    milano Repository record for ROLE OF SPHINGOSINE-1-PHOSPATE PATHWAY IN INTESTINAL EPITHELIAL CELLS AND ITS INVOLVEMENT IN INTESTINAL TUMORIGENESIS. (opens in a new tab)